Remodeling of the human retina in choroideremia: Rab escort protein 1 (REP-1) mutations

Investigative Ophthalmology and Visual Science

Volumn 47, Issue 9, 2006, Pages 4113-4120

  Jacobson, Samuel G ^a   Cideciyan, Artur V ^a   Sumaroka, Alexander ^a   Aleman, Tomas S ^a   Schwartz, Sharon B ^a   Windsor, Elizabeth A M ^a   Roman, Alejandro J ^a   Stone, Edwin M ^b   MacDonald, Ian M ^c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^c UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

RAB ESCORT PROTEIN 1; RAB PROTEIN; UNCLASSIFIED DRUG; CHM PROTEIN, HUMAN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TRANSFERASE;

ADOLESCENT; ADULT; ARTICLE; CELL ACTIVATION; CHOROIDEREMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DEPIGMENTATION; DISEASE COURSE; GENE MUTATION; HEMIZYGOTE; HUMAN; HYPERTROPHY; MALE; MEDICAL DECISION MAKING; MUELLER CELL; OPTICAL COHERENCE TOMOGRAPHY; PHOTORECEPTOR; PIGMENT EPITHELIUM; PRESCHOOL CHILD; PRIORITY JOURNAL; RETINA CONE; RETINA ROD; RETINOPATHY; SCHOOL CHILD; TREATMENT PLANNING; CHILD; GENETICS; MIDDLE AGED; MUTATION; PATHOLOGY; PSYCHOPHYSICS; RETINA;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADOLESCENT; ADULT; ALKYL AND ARYL TRANSFERASES; CHILD; CHOROIDEREMIA; HUMANS; HYPERTROPHY; MALE; MIDDLE AGED; MUTATION; PIGMENT EPITHELIUM OF EYE; PSYCHOPHYSICS; RAB GTP-BINDING PROTEINS; RETINA; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 33749140610     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.06-0424     Document Type: Article

References (50)

1. Wassle H. Parallel processing in the mammalian retina. Nat Rev Neurosci. 2004;5:1-11.
2. Kennan A, Aherne A, Humphries P. Light in retinitis pigmentosa. Trends Genet. 2005;21:103-110.
3. Ali RR, Sarra GM, Stephens C, et al. Restoration of photoreceptor ultrastructure and function in retinal degeneration slow mice by gene therapy. Nat Genet. 2000;25:306-310.
4. Acland GM, Aguirre GD, Ray J, et al. Gene therapy restores vision in a canine model of childhood blindness. Nat Genet. 2001;28:92-95.
5. Vollrath D, Feng W, Duncan JL, et al. Correction of the retinal dystrophy phenotype of the RCS rat by viral gene transfer of Mertk. Proc Natl Acad Sci USA. 2001;98:12584-12589.
6. Acland GM, Aguirre GD, Bennett J, et al. Long-term restoration of rod and cone vision by single dose rAAV-mediated gene transfer to the retina in a canine model of childhood blindness. Mol Ther. 2005;12:1072-1082.
7. Dinculescu A, Glushakova L, Min SH, Hauswirth WW. Adeno-associated virus-vectored gene therapy for retinal disease. Hum Gene Ther. 2005;16:649-663.
8. Batten ML, Imanishi Y, Tu DC, et al. Pharmacological and rAAV gene therapy rescue of visual functions in a blind mouse model of Leber congenital amaurosis. PloS Med. 2005;2:e333.
9. Rolling F. Recombinant AAV-mediated gene transfer to the retina: gene therapy perspectives. Gene Ther. 2004;11:S26-S32.
10. Preising MN, Heegard S. Recent advances in early-onset severe retinal degeneration: more than just basic research. Trends Mol Med. 2004;10:51-54.
11. Jacobson SG, Aleman TS, Cideciyan AV, et al. Identifying photoreceptors in blind eyes caused by RPE65 mutations: prerequisite for human gene therapy success. Proc Natl Acad Sci USA. 2005;102:6l77-6l82.
12. Tolmachova T, Anders R, Abrink M, et al. Independent degeneration of photoreceptors and retinal pigment epithelium in conditional knockout mouse models of choroideremia. J Clin Invest. 2006;116:386-394.
13. McCulloch C. Choroideremia: a clinical and pathologic review. Trans Am Ophthalmol Soc. 1969;67:142-195.
14. Sorsby A, Franceschetti A, Joseph R, Davey JB. Choroideremia: clinical and genetic aspects. Br J Ophthalmol. 1952;36:547-581.
15. Cremers FP, van de Pol DJ, van Kerkhoff LP, Wieringa B, Ropers HH. Cloning of a gene that is rearranged in patients with choroideraemia. Nature. 1990;347:674-677.
16. Seabra MC, Mules EH, Hume AN. Rab GTPases, intracellular traffic and disease. Trends Mol Med. 2002;8:23-30.
17. Preising M, Ayuso C. Rab escort protein 1 (REP1) in intracellular traffic: a functional and pathophysiological overview. Ophthalmic Genet. 2004;25:101-110.
18. MacDonald IM, Sereda C, McTaggert K, Mah D. Choroideremia gene testing. Expert Rev Mol Diagn. 2004;4:478-484.
19. Duncan J, Aleman TS, Gardner LM, et al. Macular pigment and lutein supplementation in choroideremia. Exp Eye Res. 2002;74:371-381.
20. Jacobson SG, Cideciyan AV, Aleman TS, et al. Crumbs homolog 1 (CRB1) mutations result in a thick human retina with abnormal lamination. Hum Mol Genet. 2003;12:1073-1078.
21. Jacobson SG, Sumaroka A, Aleman TS, et al. Nuclear receptor NR2E3 gene mutations distort human retinal laminar architecture and cause an unusual degeneration. Hum Mol Genet. 2004;13:1893-1902.
22. Cideciyan AV, Jacobson SG, Aleman TS, et al. In vivo dynamics of retinal injury and repair in the rhodopsin mutant dog model of human retinitis pigmentosa. Proc Natl Acad Sci USA. 2005;102:5233-5238.
23. Huang Y, Cideciyan AV, Papastergiou GI, et al. Relation of optical coherence tomography to microanatomy in normal and rd chickens. Invest Ophthalmol Vis Sci. 1998;39:2405-24l6.
24. Huang D, Swanson EA, Lin CP, et al. Optical coherence tomography. Science. 1991;254:1178-1181.
25. Drexler W, Morgner U, Ghanta RK, Kartner FX, Schuman JS, Fujimoto JG. Ultrahigh-resolution ophthalmic optical coherence tomography. Nat Med. 2001;7:502-507.
26. Jacobson SG, Cideciyan AV, Iannaccone A, et al. Disease expression of RP1 mutations causing autosomal dominant retinitis pigmentosa. Invest Ophthalmol Vis Sci. 2000;41:1898-1908.
27. Curcio CA, Sloan KR, Kalina RE, Hendrickson AE. Human photoreceptor topography. J Comp Neurol. 1990;292:497-523.
28. Carter-Dawson LD, LaVail MM. Rods and cones in the mouse retina. I. Structural analysis using light and electron microscopy. J Comp Neurol. 1979;188:245-262.
29. Roberts MF, Fishman GA, Roberts DK, et al. Retrospective, longitudinal, and cross sectional study of visual acuity impairment in choroideraemia. Br J Ophthalmol. 2002;86:658-662.
30. Chen S, Pickard JD, Harris NG. Time course of cellular pathology after controlled cortical impact injury. Exp Neurol. 2003;182:87-102.
31. Sutula T. Mechanisms of epilepsy progression: current theories and perspectives from neuroplasticity in adulthood and development. Epilepsy Res. 2004;60:161-171.
32. Gaudreauk SB, Blain JF, Gratton JP, Poirier J. A role for caveolin-1 in post-injury reactive neuronal plasticity. J Neurochem. 2005;92:831-839.
33. Milam AH, Li ZY, Fariss RN. Histopathology of the human retina in retinitis pigmentosa. Prog Retin Eye Res. 1998;17:175-205.
34. Li ZY, Kljavin IJ, Milam AH. Rod photoreceptor neunte sprouting in retinitis pigmentosa. J Neurosci. 1995;15:5429-5438.
35. Marc RE, Jones BW, Watt CB, Strettoi E. Neural remodeling in retinal degeneration. Prog Retin Eye Res. 2003;22:607-655.
36. Fisher SK, Lewis GP, Linberg KA, Verardo MR. Cellular remodeling in mammalian retina: results from studies of experimental retinal detachment. Prog Retin Eye Res. 2005;24:395-431.
37. Jones BW, Marc RE. Retinal remodeling during retinal degeneration. Exp Eye Res. 2005;81:123-137.
38. Wang S, Lu B, Lund RD. Morphological changes in the Royal College of Surgeons rat retina during photoreceptor degeneration and after cell-based therapy. J Comp Neurol. 2005;491:400-417.
39. Distler C, Dreher Z. Glia cells of the monkey retina: II. Muller cells. Vision Res. 1996;36:2381-2394.
40. Nishikawa S, Tamai M. Muller cells in the human foveal region. Curr Eye Res. 2001;22:34-41.
41. Bringmann A, Reichenbach A. Role of Muller cells in retinal degenerations. Front Biosci. 2001;6:E72-E92.
42. Burris C, Klug K, Ngo IT, Sterling P, Schein S. How Muller glial cells in macaque fovea coat and isolate the synaptic terminals of cone photoreceptors. J Comp Neurol. 2002;453:100-111.
43. Guidry C. The role of Muller cells in fibrocontractive retinal disorders. Prog Retin Eye Res. 2005;24:75-86.
44. Rattner A, Nathans J. The genomic response to retinal disease and injury: evidence for endothelin signaling from photoreceptors to glia. J Neurosci. 2005;25:4540-4549.
45. DiLoreto DA Jr, Martzen MR, del Cerro C, Coleman PD, del Cerro M. Muller cell changes precede photoreceptor cell degeneration in the age-related retinal degeneration of the Fischer 344 rat. Brain Res. 1995;698:1-14.
46. Gass JD. Muller cell cone, an overlooked part of the anatomy of the fovea centralis: hypotheses concerning its role in the pathogenesis of macular hole and foveomacular retinoschisis. Arch Ophthalmol. 1999;117:821-823.
47. Bok D, Yasumura D, Matthes MT, et al. Effects of adeno-associated virus-vectored ciliary neurotrophic factor on retinal structure and function in mice with a P216L rds/peripherin mutation. Exp Eye Res. 2002;74:719-735.
48. Bush RA, Lei B, Tao W, et al. Encapsulated cell-based intraocular delivery of ciliary neurotrophic factor in normal rabbit: dose-dependent effects on ERG and retinal histology. Invest Ophthalmol Vis Sci. 2004;45:2420-2430.
49. Zeiss CJ, Allore HG, Towle V, Tao W. CNTF induces dose-dependent alterations in retinal morphology in normal and rcd-1 canine retina. Exp Eye Res. 2006;82:395-404.
50. Fisher SK, Lewis GP. Muller cell and neuronal remodeling in retinal detachment and reattachment and their potential consequences for visual recovery: a review and reconsideration of recent data. Vision Res. 2003;43:887-897.